Thomas Ledowski

Professor Thomas Ledowski is a distinguished academic and medical professional at The University of Western Australia Medical School, where he serves as both a Professor and Head of the Emergency Medicine Discipline. He maintains a dual role as a Consultant Anaesthetist at Royal Perth Hospital since 2005.

Dr. Ledowski completed his medical training in Germany, specializing in Anaesthesiology at the University Dept. of Anaesthesiology, Intensive Care and Pain Medicine of the Christian-Albrechts-University Kiel in 2000. He further sub-specialized in Perioperative Intensive Care Medicine and Disaster Medicine. His credentials include M.D., P.D., DEAA, and fellowship in both the European Society of Anaesthesiology and the Australian and New Zealand College of Anaesthetists (FANZCA).

His research program focuses on the monitoring of perioperative stress and pain, with particular emphasis on neuromuscular blocking agents, their reversal mechanisms, and effects on surgical conditions and postoperative outcomes. His work spans multiple disciplines within anesthesiology and contributes to UN Sustainable Development Goals related to health and wellbeing.

Professor Ledowski has an impressive research output with 85 publications and an h-index of 30 with 2851 citations. His recent work demonstrates continued productivity and relevance in the field of anesthesiology, particularly in nociception monitoring, neuromuscular blocking agents, and postoperative pain management.

• Fellow of the Australian and New Zealand College of Anaesthetists (FANZCA)
• Fellow of the European Society of Anaesthesiology

Professor Ledowski has secured significant research funding, including two major projects funded by Merck, Sharp & Dohme Australia focusing on perioperative medicine and muscle relaxation in anesthesia. His work has garnered substantial attention across academic platforms with significant readership on Mendeley and mentions across various professional networks.

His research fingerprint reveals substantial contributions across key areas including Neuromuscular Blocking (100% relevance), Postoperative Pain (65%), Sugammadex applications (62%), Skin Conductance monitoring (60%), Sevoflurane effects (59%), Nociception measurement (55%), Muscle Relaxation techniques (52%), and Remifentanil applications (45%).